Litcius/Paper detail

High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes

Kun Yang, Hai‐Ning Wang, Rui Wei, Wenhua Xiao, Qing Tian, Congrong Wang, Jin Yang, Tianpei Hong

2021Acta Diabetologica10 citationsDOI

Topics & Concepts

MedicineExenatideFGF21Type 2 diabetesMetforminGlycemicInternal medicineQuartileConfoundingDiabetes mellitusEndocrinologyInsulinConfidence intervalReceptorFibroblast growth factorFibroblast Growth Factor ResearchParathyroid Disorders and TreatmentsDiabetes Treatment and Management
High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes | Litcius